1. Hassanpour SH and Dehghani MA. Review of cancer from perspective of molecular. Journal of Cancer Research and Practice. 2017; 4(4): 127-129. [
DOI:10.1016/j.jcrpr.2017.07.001]
2. Miller KD, Ortiz AP, Pinheiro PS, Bandi P, Minihan A, Fuchs HE, Tyson DM, Tortolero-Luna G, Fedewa SA, Jemal AM and Siegel RL. Cancer statistics for the US Hispanic/Latino population, 2021. CA: A Cancer Journal for Clinicians. 2021; 71(6): 466-487. [
DOI:10.3322/caac.21695]
3. Mattiuzzi C and Lippi G. Current cancer epidemiology. J. Epidemiology and Glob. Health. 2019; 9(4): 217-222. [
DOI:10.2991/jegh.k.191008.001]
4. Arem H and Loftfield E. Cancer epidemiology: A survey of modifiable risk factors for prevention and survivorship. Am. J. Lifestyle Med. 2018; 12(3): 200-210. [
DOI:10.1177/1559827617700600]
5. Torres-Collado AX, Knott J and Jazirehi AR. Reversal of resistance in targeted therapy of metastatic melanoma: Lessons learned from Vemurafenib (BRAFV600E-specific inhibitor). Cancers. 2018; 10(6): 157. [
DOI:10.3390/cancers10060157]
6. Sever R and Brugge JS. Signal transduction in cancer. Cold Spring Harbor Perspectives in Medicine. 2015; 5(4). A006098. [
DOI:10.1101/cshperspect.a006098]
7. Rawla P. Epidemiology of Prostate Cancer. World Journal of Oncology. 2019; 10(2): 63-89. [
DOI:10.14740/wjon1191]
8. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin. 2018; 68(6): 394-424. [
DOI:10.3322/caac.21492]
9. Hosseini SY, Danesh AK, Parvin M, Basiri A, Javadzadeh T, Safarinejad MR and Nahabedian A. Incidental prostatic adenocarcinoma in patients with PSA less than 4 ng/mL undergoing radical cystoprostatectomy for bladder cancer in Iranian men. International Braz. J. Urol. 2007; 33(2): 167-175. [
DOI:10.1590/S1677-55382007000200006]
10. Singh KK, Mridula D, Rehal J and Barnwal P. Flaxseed: a potential source of food, feed and fiber. Crit. Rev. Food Sci. Nutr. 2011; 51(3): 210-222. [
DOI:10.1080/10408390903537241]
11. Kajla P, Sharma A and Sood DR. Flaxseed-a potential functional food source. Journal of Food Science and Technol. 2015; 52: 1857-1871. [
DOI:10.1007/s13197-014-1293-y]
12. Lin X, Gingrich JR, Bao W, Li J, Haroon ZA and Demark-Wahnefried W. Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice. Urology 2002; 60(5): 919-924. [
DOI:10.1016/S0090-4295(02)01863-0]
13. Demark-Wahnefried W, Polascik TJ, George Sl, Switzer BR, Madden JF, Ruffin MT, Snyder DC, Owzar K, Hars V, Albala DM, Walther PJ, Robertson CN, Moul JW, Dunn BK, Brenner D, Minasian L, Stella P and Vollmer RT. Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiology Biomarkers & Prev. 2008; 17(12): 3577-3587. [
DOI:10.1158/1055-9965.EPI-08-0008]
14. Ezzat SM, Shouman SA, Elkhoely A, Attia YM, Elsesy MS, El Senousy AS, Choucry MA, El Gayed SH, El Sayed AA, Sattar EA and El Tanbouly N. Anticancer potentiality of lignan rich fraction of six Flaxseed cultivars. Scientific Reports. 2018; 8(1): 544. [
DOI:10.1038/s41598-017-18944-0]
15. Goyal A, Vivek Sh, Upadhyay N, Gill S and Sihag M. Flax and flaxseed oil: an ancient medicine & modern functional food. Journal of Food Science and Technology. 2014; 51: 1633-1653. [
DOI:10.1007/s13197-013-1247-9]
16. Buckner Al, Buckner CA, Montaut S and Lafrenie RM. Treatment with flaxseed oil induces apoptosis in cultured malignant cells. Heliyon. 2019; 5(8). e02251. [
DOI:10.1016/j.heliyon.2019.e02251]
17. Tannous S, Haykal T, Dhaini J, Hodroj MH and Rizk S. The anti-cancer effect of flaxseed lignan derivatives on different acute myeloid leukemia cancer cells. Biomedicine & Pharmacotherapy. 2020; 132: 110884. [
DOI:10.1016/j.biopha.2020.110884]
18. Zhang K and Waxman DJ. PC3 prostate tumor-initiating cells with molecular profile FAM65Bhigh/MFI2low/LEF1low increase tumor angiogenesis. Molecular Cancer. 2010; 9: 319. 1-13. [
DOI:10.1186/1476-4598-9-319]
19. Shirkavand A, Farivar Sh, Mohajerani E, Ataie-Fashtami L and Ghazimoradi MH. Non‐invasive reflectance spectroscopy for normal and cancerous skin cells refractive index determination: An in vitro study. Lasers in Surgery and Medicine. 2019; 51(8): 742-750. [
DOI:10.1002/lsm.23095]
20. Shirkavand A, Mohajerani E, Farivar Sh, Ataie-Fashtami L and Ghazimoradi MH. Monitoring the response of skin melanoma cell line (A375) to treatment with vemurafenib: A pilot in vitro optical spectroscopic study. Photobiomodul. Photomed. Laser Surg. 2021; 39(3): 164-177. [
DOI:10.1089/photob.2020.4887]
21. Kamalidehghan B, Ghafouri-Fard S, Motevaseli E and Ahmadipour F. Inhibition of human prostate cancer (PC-3) cells and targeting of PC-3-derived prostate cancer stem cells with koenimbin, a natural dietary compound from Murraya koenigii (L) Spreng. Drug. Des. Devel. Ther. 2018; 12: 1119-1133. [
DOI:10.2147/DDDT.S156826]
22. Shirkavand A, Mohajerani E, Farivar Sh, Ataie-Fashtami L and Ghazimoradi MH. Quantitative autofluorescence imaging of A375 human melanoma cell samples: a pilot study. J. Lasers Med. Sci. 2021; 12: e4. [
DOI:10.34172/jlms.2021.04]
23. Mokhtar KI, Nordin NS, Mustafa BE, Lestari W, Ikhwan SJA, Darnis DS, Ahmad A and Kannan TP. Effects of flaxseed extract on the viability of stem cells from human extracted deciduous teeth (SHED). Frontiers in Bioengineering and Biotechnology. 2016. [
DOI:10.31436/imjm.v16i2.1107]
24. Lakshmanan I and Batra SK. Protocol for apoptosis assay by flow cytometry using annexin V staining method. Bio. Protocol. 2013; 3(6): e374-e374. [
DOI:10.21769/BioProtoc.374]
25. Hingorani R, Deng J, Elia J, McIntyre C, and Mitta D. Detection of Apoptosis using the BD Annexin V FITC assay on the BD FACSVerse™ system. Biosciences, Application Not, 2011
26. Farivar Sh and Ghazimoradi MH. DNA and RNA extraction from low amount of blood volume. Forensic Science International. 2019; 303: 109931. [
DOI:10.1016/j.forsciint.2019.109931]
27. Bello AP and Masip TC. Prostate cancer epidemiology. Arch. Esp. Urol. 2014; 67(5): 373-382.
28. Thompson LU, Rickard SE, Cheung F, Kenaschuk EO and Obermeyer WR. Variability in anticancer lignan levels in flaxseed. Nutr. Cancer. 1997; 27(1): 26-30. [
DOI:10.1080/01635589709514497]
29. Mason JK and Thompson LU. Flaxseed and its lignan and oil components: can they play a role in reducing the risk of and improving the treatment of breast cancer? Appl. Physiol. Nutr. Metab. 2014; 39(6): 663-678. [
DOI:10.1139/apnm-2013-0420]
30. Liu X-Y, Pestka S and Shi Y-F. Recent advances in cancer research and therapy. 2012.
31. Casimiro MC, Crosariol M, Loro E, Li Z and Pestell RG. Cyclins and cell cycle control in cancer and disease. Genes Cancer. 2012; 3(11-12): 649-657. [
DOI:10.1177/1947601913479022]